LYME AND CO-INFECTION NOSODE- angelica archangelica, kali muriaticum, yucca filamentosa, cartilago suis, phytolacca decandra, hydrastis canadensis, rhus tox, causticum, magnesia phosphorica, manganum metallicum, oxalicum acidum, arnica montana, babesia microti, borrelia burgdorferi nosode, latrodectus mactans, citricum acidum, cytomegalovirus nosode, rickettsia nosode (rickettsia prowazekii), chlamydia trachomatis, ledum palustre liquid 
Bhp Holdings, Inc.

Disclaimer: This homeopathic product has not been evaluated by the Food and Drug Administration for safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective.

----------

Drug Facts:

ACTIVE INGREDIENTS:

Angelica Archangelica 2X, Kali Muriaticum 3X, Yucca Filamentosa 3X, Cartilago Suis 4X, 6X, 12X, Phytolacca Decandra 4X, 12X, 30X, Hydrastis Canadensis 5X, Rhus Tox 6X, Causticum 6X, 12X, 30X, Magnesia Phosphorica 8X, Manganum Metallicum 8X, Oxalicum Acidum 8X, 12X, Arnica Montana 8X, 100X, 1000X, Babesia Microti 12X, 30X, 60X, Borrelia Burgdorferi Nosode 12X, 30X, 60X, Latrodectus Mactans 12X, 30X, 60X, Citricum Acidum 6C, Cytomegalovirus Nosode 6C, Rickettsia Nosode (Rickettsia prowazekii) 8C, Chlamydia Trachomatis 12C, Ledum Palustre 30C.

INDICATIONS:

Supports the immune system for host resistance to Lyme disease and co-infections.

WARNINGS:

If pregnant or nursing ask your health Care Practitioner before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Do not use if tamper evident seal is broken or missing.

Store in a cool, dry and dark place.

KEEP OUT OF REACH OF CHILDREN:

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

DIRECTIONS:

Take 10 drops 1 to 3 times per day under the tongue 30 minutes before meal or as directed by a Health Care Practitioner.
Consult your physician for use in children under 12 years of age.

INDICATIONS:

Supports the immune system for host resistance to Lyme disease and co-infections.

INACTIVE INGREDIENTS:

Demineralized Water and Organic Alcohol (Ethanol) 20%.

QUESTIONS:

Manufactured for: BHP Holdings, Inc.

Woodinville, WA 98072 Phone: 425-462-8414

www.biopureus.com info@biopureus.com

Formulated and produced under the guidelines of the Homeopathic Pharmacopoeia of the United States. 

PACKAGE LABEL DISPLAY:

58048-0005-1

BioPure

Lyme & Co-Infection

NOSODE

HOMEOPATHIC

2 fl.oz (60mL)

Lyme & Co-Infection Nosode

LYME AND CO-INFECTION NOSODE 
angelica archangelica, kali muriaticum, yucca filamentosa, cartilago suis, phytolacca decandra, hydrastis canadensis, rhus tox, causticum, magnesia phosphorica, manganum metallicum, oxalicum acidum, arnica montana, babesia microti, borrelia burgdorferi nosode, latrodectus mactans, citricum acidum, cytomegalovirus nosode, rickettsia nosode (rickettsia prowazekii), chlamydia trachomatis, ledum palustre liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:58048-0005
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
ANGELICA ARCHANGELICA ROOT (UNII: DTN01M69SN) (ANGELICA ARCHANGELICA ROOT - UNII:DTN01M69SN) ANGELICA ARCHANGELICA ROOT2 [hp_X]  in 1 mL
POTASSIUM CHLORIDE (UNII: 660YQ98I10) (POTASSIUM CATION - UNII:295O53K152) POTASSIUM CATION3 [hp_X]  in 1 mL
YUCCA FILAMENTOSA (UNII: T6VR38UJ9I) (YUCCA FILAMENTOSA - UNII:T6VR38UJ9I) YUCCA FILAMENTOSA3 [hp_X]  in 1 mL
SUS SCROFA CARTILAGE (UNII: 73ECW5WG2F) (SUS SCROFA CARTILAGE - UNII:73ECW5WG2F) SUS SCROFA CARTILAGE4 [hp_X]  in 1 mL
PHYTOLACCA AMERICANA ROOT (UNII: 11E6VI8VEG) (PHYTOLACCA AMERICANA ROOT - UNII:11E6VI8VEG) PHYTOLACCA AMERICANA ROOT4 [hp_X]  in 1 mL
GOLDENSEAL (UNII: ZW3Z11D0JV) (GOLDENSEAL - UNII:ZW3Z11D0JV) GOLDENSEAL5 [hp_X]  in 1 mL
TOXICODENDRON PUBESCENS LEAF (UNII: 6IO182RP7A) (TOXICODENDRON PUBESCENS LEAF - UNII:6IO182RP7A) TOXICODENDRON PUBESCENS LEAF6 [hp_X]  in 1 mL
CAUSTICUM (UNII: DD5FO1WKFU) (CAUSTICUM - UNII:DD5FO1WKFU) CAUSTICUM6 [hp_X]  in 1 mL
MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE (UNII: HF539G9L3Q) (MAGNESIUM CATION - UNII:T6V3LHY838) MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE8 [hp_X]  in 1 mL
MANGANESE (UNII: 42Z2K6ZL8P) (MANGANESE - UNII:42Z2K6ZL8P) MANGANESE8 [hp_X]  in 1 mL
OXALIC ACID (UNII: 9E7R5L6H31) (OXALIC ACID - UNII:9E7R5L6H31) OXALIC ACID8 [hp_X]  in 1 mL
ARNICA MONTANA (UNII: O80TY208ZW) (ARNICA MONTANA - UNII:O80TY208ZW) ARNICA MONTANA8 [hp_X]  in 1 mL
BABESIA MICROTI (UNII: 1948X6KEG3) (BABESIA MICROTI - UNII:1948X6KEG3) BABESIA MICROTI12 [hp_X]  in 1 mL
BORRELIA BURGDORFERI (UNII: 0J8NV9V5Q8) (BORRELIA BURGDORFERI - UNII:0J8NV9V5Q8) BORRELIA BURGDORFERI12 [hp_X]  in 1 mL
LATRODECTUS MACTANS (UNII: XJJ7QA858R) (LATRODECTUS MACTANS - UNII:XJJ7QA858R) LATRODECTUS MACTANS12 [hp_X]  in 1 mL
ANHYDROUS CITRIC ACID (UNII: XF417D3PSL) (ANHYDROUS CITRIC ACID - UNII:XF417D3PSL) ANHYDROUS CITRIC ACID6 [hp_C]  in 1 mL
HUMAN HERPESVIRUS 5 (UNII: 7COI029E6K) (HUMAN HERPESVIRUS 5 - UNII:7COI029E6K) HUMAN HERPESVIRUS 56 [hp_C]  in 1 mL
RICKETTSIA PROWAZEKII (UNII: TVS414L9M5) (RICKETTSIA PROWAZEKII - UNII:TVS414L9M5) RICKETTSIA PROWAZEKII8 [hp_C]  in 1 mL
CHLAMYDIA TRACHOMATIS (UNII: T6NI39QU44) (CHLAMYDIA TRACHOMATIS - UNII:T6NI39QU44) CHLAMYDIA TRACHOMATIS12 [hp_C]  in 1 mL
LEDUM PALUSTRE TWIG (UNII: 877L01IZ0P) (LEDUM PALUSTRE TWIG - UNII:877L01IZ0P) LEDUM PALUSTRE TWIG30 [hp_C]  in 1 mL
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
ALCOHOL (UNII: 3K9958V90M)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:58048-0005-160 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product03/17/202009/19/2027
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved homeopathic03/17/202009/19/2027
Labeler - Bhp Holdings, Inc. (046238227)
Registrant - Apotheca Company (844330915)
Establishment
NameAddressID/FEIBusiness Operations
Apotheca Company844330915manufacture(58048-0005) , api manufacture(58048-0005) , label(58048-0005) , pack(58048-0005)

Revised: 6/2023
Document Id: 88e0c163-99e8-45bb-8911-8d29370dd909
Set id: f6186157-256f-4454-b122-f7665e3286f4
Version: 3
Effective Time: 20230601
 
Bhp Holdings, Inc.